Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1971 1
1972 5
1973 1
1974 1
1975 1
1978 1
1980 1
1981 1
1982 1
1983 1
1984 2
1986 1
1988 1
1989 1
1990 2
1991 1
1992 1
1993 3
1994 4
1995 1
1996 4
1997 3
1999 2
2000 7
2001 7
2002 8
2003 11
2004 9
2005 12
2006 10
2007 7
2008 7
2009 9
2010 3
2011 6
2012 5
2013 2
2014 2
2015 2
2016 1
2017 3
2019 3
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 12046376

153 results
Results by year
Filters applied: . Clear all
Page 1
Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
Blair L. Blair L. Can Fam Physician. 2002 Apr;48:831, 833, 836-8. Can Fam Physician. 2002. PMID: 12046376 Free PMC article. No abstract available.
Industry warily eyes new Medicare drug plan.
Vastag B. Vastag B. Nat Biotechnol. 2006 Feb;24(2):120. doi: 10.1038/nbt0206-120. Nat Biotechnol. 2006. PMID: 16465141 No abstract available.
The draft pharmaceutical policy: the weakest link.
Desrosiers G. Desrosiers G. Perspect Infirm. 2005 Mar-Apr;2(4):8-11. Perspect Infirm. 2005. PMID: 15816423 English, French. No abstract available.
A catastrophe in health care.
Cassels A. Cassels A. Can Nurse. 2009 Nov;105(9):52. Can Nurse. 2009. PMID: 19998693 No abstract available.
Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?
Bourassa Forcier M, Noël F. Bourassa Forcier M, et al. Healthc Policy. 2013 Aug;9(1):65-75. Healthc Policy. 2013. PMID: 23968675 Free PMC article.
Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
Ozdemir V, Williams-Jones B. Ozdemir V, et al. Nat Biotechnol. 2006 Nov;24(11):1324-6; author reply 1326-7. doi: 10.1038/nbt1106-1324. Nat Biotechnol. 2006. PMID: 17093467 No abstract available.
Evaluating the effects of Quebec's private-public drug insurance system.
Morgan SG, Gagnon MA, Charbonneau M, Vadeboncoeur A. Morgan SG, et al. CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726. CMAJ. 2017. PMID: 29018085 Free PMC article. Review. No abstract available.
India: 50 years after independence.
Miller DD, Nayak AR. Miller DD, et al. Nat Biotechnol. 1997 Aug;15(8):727-9. doi: 10.1038/nbt0897-727. Nat Biotechnol. 1997. PMID: 9255782 No abstract available.
Drug companies should target drug plans, rather than physicians, consultant says.
Silversides A. Silversides A. CMAJ. 2010 Jan 12;182(1):E21-2. doi: 10.1503/cmaj.109-3101. Epub 2009 Nov 9. CMAJ. 2010. PMID: 19901047 Free PMC article. No abstract available.
Disease management. Getting out from under drug companies' shadows.
Heimoff S. Heimoff S. Manag Care. 2000 Mar;9(3):39-40, 42-3. Manag Care. 2000. PMID: 11066212 Free article. No abstract available.
153 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback